Skip to main content

Table 1 The treatment groups

From: Transcriptome investigation of anti‐inflammation and immuno‐regulation mechanism of taurochenodeoxycholic acid

Group Treatment
TCDCA concentration (M)
AA rat FLS group (FCA group) -
AA rat FLS + TCDCA high dose treatment (AT10 group) 1 × 10− 5
AA rat FLS + TCDCA medium dose treatment (AT1 group) 1 × 10− 6
AA rat FLS + TCDCA low dose treatment (AT01 group) 1 × 10− 7
  1. AA Adjuvant arthritis, FLS Fibroblast-like synoviocytes, TCDCA Taurochenodeoxycholic acid